15 Results for "

BCRP/ABCG2

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "BCRP/ABCG2" in MCE Product Catalog:

  • Categories Recommended:
    More
55
55 Cited Publications
Cat. No.: HY-10010
CAS No.: 461054-93-3
Purity:  99.97%
Target:  

BCRP

Research Areas:  

Cancer

Ko 143 is a potent and selective ATP-binding cassette subfamily G member 2 (ABCG2/BCRP) inhibitor. Ko 143 displays >200-fold selectivity over P-gp and MRP-1 transporters .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-12757
CAS No.: 912287-56-0
Purity:  99.65%
Target:  

BCRP

Research Areas:  

Cancer

YHO-13177, a acrylonitrile derivative, is an orally active, potent and specific inhibitor of breast cancer resistance protein (BCRP) and ABCG2 with an IC50 value of 10 nM. YHO-13177 potentiates the cytotoxicity of SN-38 in HCT116 and A549 cells that express BCRP. YHO-13177 combined with Irinotecan (HY-16562) significantly suppresses the tumor growth in an HCT116/BCRP xenograft model .
loading...
    loading...
Cat. No.: HY-12758
CAS No.: 1346753-00-1
Purity:  99.16%
Target:  

BCRP

Research Areas:  

Cancer

YHO-13351 is an orally active ABCG2 inhibitor . YHO-13351 modulates the function of ABCG2, blocks BCRP-mediated compound efflux, downregulates the expression of breast cancer resistance protein at the post-transcriptional level, and reverses ABCG2-associated tolerance. YHO-13351 restores the toxicity of SN-38 to SN-38-resistant cancer cells and sensitizes cancer cells to Irinotecan. YHO-13351 is a water-soluble prodrug that is rapidly converted to YHO-13177 (HY-12757) in mice. YHO-13351 prolongs the median survival time of mice bearing cancer cell xenografts when combined with IMMU-132. YHO-13351 extends the survival time of tumor-bearing mice and inhibits the growth of xenograft tumors when combined with Irinotecan. YHO-13351 can be used for the research of breast cancer, gastric cancer, BCRP-mediated drug-resistant cancers, and cervical cancer .
loading...
    loading...
Cat. No.: HY-149469
CAS No.: 19056-75-8
BCRP/ABCG2-IN-1 is the inhibitor of breast cancer resistance protein (BCRP/ABCG2), with IC50 of 5.98 μM, that can be used in multidrug resistance of breast cancer .
loading...
    loading...
Cat. No.: HY-168572
CAS No.: 2944457-11-6
Target:  

BCRP

Research Areas:  

Cancer

MZ82, Ko 143 (HY-10010) derivative, is a ATP-binding cassette subfamily G member 2 (ABCG2/BCRP) inhibitor with the IC50 of ~23 nM. MZ82 not only shows greatly improved metabolic stability over Ko 143 (HY-10010) in liver microsomes but also in mice, and is able to penetrate into the brain .
loading...
    loading...
Cat. No.: HY-W082856A
CAS No.: 155048-06-9
Target:  

BCRP

Research Areas:  

Cancer

Butein tetramethyl ether (Compound 20) is a potent and selective breast cancer resistance protein/ATP-binding cassette subfamily G member 2 (BCRP/ABCG2) inhibitor. Butein tetramethyl ether has inhibitory potencies against MCF-7 MX and MDCK BCRP cells with IC50 values of 2.2 and 1.03 μM, respectively. Butein tetramethyl ether is promising for research of cancers .
loading...
    loading...
Cat. No.: HY-122416
CAS No.: 68236-11-3
Synonyms: Lonchocarpol A; Senegalensin
6,8-Diprenylnaringenin (Lonchocarpol A; Senegalensin) is a potent BCRP/ABCG2 inhibitor (IC50 = 0.410 μM) and a non-competitive allosteric PTP1B inhibitor (IC50 = 1.04 μM; Ki = 1.56 μM) that is isolated from Humulus lupulus. 6,8-Diprenylnaringenin produces non-competitive allosteric inhibition by locking the WPD catalytic loop of PTP1B in an inactive open conformation, while simultaneously binding to and inhibiting the ABCG2 drug efflux pump. 6,8-Diprenylnaringenin also exhibits antibacterial activity against MRSA (MIC = 6-13 μM) and antioxidant activity. 6,8-Diprenylnaringenin is used in research on type 2 diabetes, obesity, MRSA infection, and atherosclerosis .
loading...
    loading...
Cat. No.: HY-P703266
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: ABCG2; CDw338; ATP Binding Cassette Subfamily G Member 2 (JR Blood Group); Broad Substrate Specificity ATP-Binding Cassette Transporter ABCG2 Isoform 1 (Junior Blood Group); BCRP; ATPbinding Cassette Transporter ABCG2; ABCP; ATP-Binding Cassette Transport
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P703267
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: ABCG2; CDw338; ATP Binding Cassette Subfamily G Member 2 (JR Blood Group); Broad Substrate Specificity ATP-Binding Cassette Transporter ABCG2 Isoform 1 (Junior Blood Group); BCRP; ATPbinding Cassette Transporter ABCG2; ABCP; ATP-Binding Cassette Transport
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P84881
Synonyms: CD338; ABCP; BCRP; BCRP1; MXR; ABCG2; Broad substrate specificity ATP-binding cassette transporter ABCG2; ATP-binding cassette sub-family G member 2; Breast cancer resistance protein; CDw338; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; Urate exporter

Host:  

Mouse

Application:  

WB, IHC-P, ICC/IF, FC, ELISA

Reactivity:  

Human, Mouse, Rat, Rabbit, Monkey

loading...
    loading...
Cat. No.: HY-P87841
Synonyms: CD338; ABCP; BCRP; BCRP1; MXR; ABCG2; Broad substrate specificity ATP-binding cassette transporter ABCG2; ATP-binding cassette sub-family G member 2; Breast cancer resistance protein; CDw338; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; Urate exporter

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P84881A
Synonyms: CD338; ABCP; BCRP; BCRP1; MXR; ABCG2; Broad substrate specificity ATP-binding cassette transporter ABCG2; ATP-binding cassette sub-family G member 2; Breast cancer resistance protein; CDw338; Mitoxantrone resistance-associated protein; Placenta-specific ATP-binding cassette transporter; Urate exporter

Host:  

Mouse

Application:  

WB, IHC-P, ICC/IF, FC, ELISA

Reactivity:  

Human, Mouse, Rat, Rabbit, Monkey

loading...
    loading...
Cat. No.: HY-10010R
CAS No.: 461054-93-3
Research Areas:  

Cancer

Ko 143 (Standard) is the analytical standard of Ko 143 (HY-10010). This product is intended for research and analytical applications. Ko 143 is a potent and selective ATP-binding cassette subfamily G member 2 (ABCG2/BCRP) inhibitor. Ko 143 displays >200-fold selectivity over P-gp and MRP-1 transporters .
loading...
    loading...
Cat. No.: HY-118083
CAS No.: 7555-80-8
Synonyms: MRS923
Target:  

BCRP

Research Areas:  

Cancer

Pentamethoxymorin (MRS923) is a selective breast cancer resistance protein (BCRP/ABCG2) inhibitor. Pentamethoxymorin shows selectivity for BCRP over P-gp and MRP1. Pentamethoxymorin inhibits MDCK BCRP cells with IC50 vaues of 5.98 μM and 5.94 μM in Hoechst 33342 (HY-15559) assay and Pheophorbide A (HY-125665) assay, respectively. Pentamethoxymorin can be used for the study of ccancer .
loading...
    loading...
Cat. No.: HY-189363
Target:  

P-glycoprotein BCRP

Research Areas:  

Cancer

P-gp/BCRP-IN-3 is a dual-target inhibitor that acts on P-gp (ABCB1) and BCRP (ABCG2) transporters. P-gp/BCRP-IN-3 directly binds to both transporters, blocks efflux function without affecting protein expression, and restores intracellular accumulation of chemotherapeutic substrates. P-gp/BCRP-IN-3 enhances tumor accumulation and antitumor activity of Mitoxantrone (HY-13502) in colorectal cancer xenograft models. P-gp/BCRP-IN-3 is applicable for cancer-related research .
loading...
    loading...
  • 1